Home / Rocuronium Bromide / United States
US ATC M03AC09 · updated 2 Nov 2026
Rocuronium Bromide shortage in United States
Is there a Rocuronium Bromide shortage in United States?
Yes. As of 2 Nov 2026, 26 Rocuronium Bromide products are reported short in United States, the first since 15 Feb 2023. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Switzerland, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Hikma Pharmaceuticals USA, Inc. | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Hikma Pharmaceuticals USA, Inc. | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) | Sandoz Inc. | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) | Sandoz Inc. | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) | Fresenius Kabi USA, LLC | 15 Feb 2023 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) | Fresenius Kabi USA, LLC | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) | Fresenius Kabi USA, LLC | 15 Feb 2023 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) | Fresenius Kabi USA, LLC | 15 Feb 2023 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) | Fresenius Kabi USA, LLC | 15 Feb 2023 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) | Mylan Institutional, a Viatris Company | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) | Mylan Institutional, a Viatris Company | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) | Meitheal Pharmaceuticals, Inc. | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) | Meitheal Pharmaceuticals, Inc. | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) | Hospira, Inc., a Pfizer Company | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) | Hospira, Inc., a Pfizer Company | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | XGen Pharmaceuticals DJB, Inc. | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) | Baxter Healthcare | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) | Eugia US LLC | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) limited | Piramal Critical Care Inc. | 15 Feb 2023 | not given | Increased demand Demand increase for the drug |
| US | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) | Hospira, Inc., a Pfizer Company | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) | Hospira, Inc., a Pfizer Company | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | XGen Pharmaceuticals DJB, Inc. | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) | Baxter Healthcare | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) | Eugia US LLC | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) | Piramal Critical Care Inc. | 15 Feb 2023 | not given | Not stated |
| US | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) | Sagent Pharmaceuticals | 15 Feb 2023 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).